Filing Details
- Accession Number:
- 0001493152-24-033277
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-20 16:35:17
- Reporting Period:
- 2024-08-15
- Accepted Time:
- 2024-08-20 16:35:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1708599 | Serina Therapeutics Inc. | SER | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1329505 | Gregory Bailey | 601 Genome Way, Suite 2001 Huntsville AL 35806 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-08-15 | 6,400 | $6.65 | 33,006 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-08-16 | 6,400 | $7.31 | 39,406 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2024-08-19 | 6,400 | $7.93 | 45,806 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.55 per share to a high of $7.94 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
- The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.12 per share to a high of $8.02 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
- The price reflects the weighted average purchase price of multiple transactions ranging from a low of $7.24 per share to a high of $8.57 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.